Home/Ophidion/Douglas J. MacNeil, Ph.D.

DJ

Douglas J. MacNeil, Ph.D.

VP of Preclinical Development

Therapeutic Areas

Neurodegenerative Diseases Central Nervous System (CNS) Disorders

Ophidion Pipeline

Drug	Indication	Phase
Platform-derived programs	Neurodegenerative Diseases (unspecified)	Preclinical

Leadership Team at Ophidion

Yacoub Habib, Ph.D., MBA

Chief Executive Officer and Chairman of the Board

Douglas Greene, M.D.

Chief Development Officer

View full Ophidion profile